STOCK TITAN

Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024, at 12:00 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website.
Positive
  • None.
Negative
  • None.

FRANKLIN, Tenn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that its CEO, Andrew Toy, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 12:00 p.m. Eastern Time.

A live webcast of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com


FAQ

What is the date of the 42nd Annual J.P. Morgan Healthcare Conference presentation by Clover Health Investments, Corp. CEO, Andrew Toy?

The presentation will be on January 11, 2024.

Where can I access the live webcast of the presentation by Clover Health Investments, Corp. CEO, Andrew Toy?

The live webcast will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.

Clover Health Investments, Corp

NASDAQ:CLOV

CLOV Rankings

CLOV Latest News

CLOV Stock Data

318.37M
375.12M
7.38%
24.46%
8.88%
Direct Health and Medical Insurance Carriers
Finance and Insurance
Link
United States of America
FRANKLIN

About CLOV

clover health (nasdaq: clov) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcarewe aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. we do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. this strategy is underpinned by our proprietary software platform, the clover assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care.making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. we offer affordable medicare advantage plans with extensive benefits, provide primary care physicians with the clover a